| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/10/2015 | CA2573262C Conjugates of a gm-csf moiety and a polymer |
| 02/05/2015 | WO2015017715A1 Drug delivery method |
| 02/05/2015 | WO2015017552A1 Antibody drug conjugates (adc) that bind to cd37 proteins |
| 02/05/2015 | WO2015017519A1 Block copolymers and their conjugates or complexes with oligonucleotides |
| 02/05/2015 | WO2015016789A1 Powder formulation of valganciclovir |
| 02/05/2015 | WO2015016667A1 Orally disintegrating film preparation containing donepezil or pharmaceutically acceptable salt thereof, and preparation method therefor |
| 02/05/2015 | WO2015016354A1 Liposomes and vaccine composition for inducing cytotoxic t cell activity |
| 02/05/2015 | WO2015016295A1 Pharmaceutical preparation comprising aminopyrazole derivative |
| 02/05/2015 | WO2015016256A1 Tablet |
| 02/05/2015 | WO2015015498A1 Methods of use of sphingolipid polyalkylamine oligonucleotide compounds |
| 02/05/2015 | WO2015015496A1 Sphingolipid-polyalkylamine-oligonucleotide compounds |
| 02/05/2015 | WO2015014980A1 Composition comprising tapentadol in a dissolved form |
| 02/05/2015 | WO2015014965A1 Vesicles |
| 02/05/2015 | WO2015014879A1 Use of anti-muc1 maytansinoid immunoconjugate antibody for the treatment of solid tumors |
| 02/05/2015 | WO2015014870A1 Diagnosis and therapy of cancer involving cancer stem cells |
| 02/05/2015 | WO2015014756A1 Tumour-targeted theranostic |
| 02/05/2015 | WO2015014653A1 Aqueous sustained release compositions of lhrh analogues |
| 02/05/2015 | WO2015014376A1 Diagnosis and therapy of cancer involving cancer stem cells |
| 02/05/2015 | WO2015014228A1 Glp-1 analog fusion protein and preparation method and use thereof |
| 02/05/2015 | WO2015013821A1 Composition comprising polyglucosamine-glyoxylate solutions mixed with hyaluronan |
| 02/05/2015 | WO2015013772A1 Compositions and preparation methods of low melting ionic salts of poorly- water soluble drugs |
| 02/05/2015 | US20150038694 Glucose derivatives bound to arsenic for use in the treatment of tumour |
| 02/05/2015 | US20150038690 GELATIN-BASED NANOPARTICLE COMPLEX FOR TUMOR-TARGETED DELIVERY OF siRNA AND METHOD FOR PREPARING THE SAME |
| 02/05/2015 | US20150038686 Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites |
| 02/05/2015 | US20150038684 Bispecific chimeric antigen receptors and therapeutic uses thereof |
| 02/05/2015 | US20150038678 Interleukin-10 Polypeptide Conjugates and Their Uses |
| 02/05/2015 | US20150038594 Oral dispersible films |
| 02/05/2015 | US20150038593 Disaggregation of aggregated nanodiamond clusters |
| 02/05/2015 | US20150038578 Methods and apparatuses for surface functionalization and coating of nanocrystals |
| 02/05/2015 | US20150038570 Compositions and products containing s-equol, and methods for their making |
| 02/05/2015 | US20150038565 Long acting compositions |
| 02/05/2015 | US20150038562 Modified L-nucleic Acid |
| 02/05/2015 | US20150038540 Instantly wettable oral film dosage form without surfactant or polyalcohol |
| 02/05/2015 | US20150038537 Agents For The Control Of Parasites On Animals |
| 02/05/2015 | US20150038532 Pharmaceutical Composition Of A Potent HCV Inhibitor For Oral Administration |
| 02/05/2015 | US20150038524 Crystalline naloxol-peg conjugate |
| 02/05/2015 | US20150038522 Combined anticancer drug sensitivity-determining marker |
| 02/05/2015 | US20150038491 Solid ivabradine-containing composition |
| 02/05/2015 | US20150038477 Orally administrable gallium compositions and methods of use |
| 02/05/2015 | US20150038475 Testosterone undecanoate compositions |
| 02/05/2015 | US20150038473 Stable povidone-iodine compositions with steroids or non-steroidal anti-inflammatories |
| 02/05/2015 | US20150038454 Antimicrobial compositions and methods of use |
| 02/05/2015 | US20150038439 Method for preparing suspensions of low-solubility materials |
| 02/05/2015 | US20150038429 Etoposide and doxorubicin conjugates for drug delivery |
| 02/05/2015 | US20150038423 Delivery of therapeutic agents by a collagen binding protein |
| 02/05/2015 | US20150038422 Unit dosage forms of pharmaceutical compositions comprising a polymer-factor viii polypeptide conjugate |
| 02/05/2015 | US20150038415 Process for the manufacturing of a drug delivery system based on a polymer comprising a dispersed bioactive agent |
| 02/05/2015 | US20150038403 Compounds That Bind to the Erythropoietin Receptor |
| 02/05/2015 | US20150037442 Composition to Enhance the Bioavailability of Curcumin |
| 02/05/2015 | US20150037438 Chewable gelled emulsions |
| 02/05/2015 | US20150037437 Glioma treatment |
| 02/05/2015 | US20150037427 Nano delivery systems |
| 02/05/2015 | US20150037424 Sustained release oral solid preparation |
| 02/05/2015 | US20150037421 Arrdc1-mediated microvesicles (armms) and uses thereof |
| 02/05/2015 | US20150037420 Sustained Release Formulation Comprising Octreotide and Two or More Polyactide-co-glycolide Polymers |
| 02/05/2015 | US20150037419 Functional PLA-PEG Copolymers, the Nanoparticles Thereof, Their Preparation and Use for Targeted Drug Delivery and Imaging |
| 02/05/2015 | US20150037413 Tamper resistant dosage forms |
| 02/05/2015 | US20150037412 Tamper resistant dosage forms |
| 02/05/2015 | US20150037411 Tamper resistant dosage forms |
| 02/05/2015 | US20150037410 Pharmaceutical compositions of ranolazine and dronedarone |
| 02/05/2015 | US20150037408 Delayed Release Pharmaceutical Compositions of Salsalate |
| 02/05/2015 | US20150037405 Pharmaceutical compositions of levodopa and carbidopa |
| 02/05/2015 | US20150037400 Cytotoxic agents |
| 02/05/2015 | US20150037398 Molecule mixture comprising an amphipathic molecule type a, which has a positive total charge in the hydrophilic range, and an amphipathic molecule type b and a polyphenol c, method for producing said molecule mixture and use thereof |
| 02/05/2015 | US20150037397 Pharmaceutical compositions of pyridinium and quinolinium derivatives |
| 02/05/2015 | US20150037396 Targeted Delivery of Anti-Fungal Agents |
| 02/05/2015 | US20150037395 Transdermal hormone delivery system: compositions and mtehods |
| 02/05/2015 | US20150037394 Drug delivery formulations |
| 02/05/2015 | US20150037388 Edible slow dissolving film for treating oral ulcerations |
| 02/05/2015 | US20150037378 Anti-Microbial Formulations Containing Nitric Oxide |
| 02/05/2015 | US20150037377 Substituted cellulose acetates and uses thereof |
| 02/05/2015 | US20150037372 pH-Responsive High-Density Lipoprotein-Like Particle Complex |
| 02/05/2015 | US20150037360 Lysosome-Cleavable Linker |
| 02/05/2015 | US20150037359 Xten conjugate compositions and methods of making same |
| 02/05/2015 | US20150037358 Composition and Methods for Treating Cancer |
| 02/05/2015 | US20150037348 Human antibodies that bind human il-12 and methods for producing |
| 02/05/2015 | US20150037340 Novel antigen binding protein and its use as addressing product for the treatment of cancer |
| 02/05/2015 | US20150037335 Therapeutic use of p75ntr neurotrophin binding protein |
| 02/05/2015 | US20150037331 Il-31 monoclonal antibodies |
| 02/05/2015 | US20150037328 Anti-cxcr4 antibodies and antibody-drug conjugates |
| 02/05/2015 | US20150037326 Pharmaceutical composition comprising a polymeric carrier cargo complex and an antigen |
| 02/05/2015 | US20150037311 Targeted lysosomal enzyme compounds |
| 02/05/2015 | US20150037283 Combination Therapy With Anti-CD74 Antibodies Provides Enhanced Toxicity to Malignancies, Autoimmune Disease and Other Diseases |
| 02/05/2015 | US20150037279 Sustained release formulation of interleukin-10 for wound treatment and related methods |
| 02/05/2015 | US20150037275 Rifaximin complexes |
| 02/05/2015 | US20150037252 Method for the Treatment of a Solid Tumour |
| 02/05/2015 | US20150035195 Cosmetic textile fiber, method for obtaining it and use thereof |
| 02/04/2015 | EP2832730A1 Mirabegron-containing pharmaceutical composition |
| 02/04/2015 | EP2832373A1 Method to block site-specifically chemokine-related inflammatory processes in vascular diseases and metastasis |
| 02/04/2015 | EP2832372A1 Composition for enteric hard capsule and enteric hard capsule prepared using the composition |
| 02/04/2015 | EP2832371A1 Application of gastrodin as solubilizer and method for preparing injection or powder for injection |
| 02/04/2015 | EP2832370A1 Method for producing drugs and biologically active agents |
| 02/04/2015 | EP2832361A1 Aqueous sustained release compositions of LHRH analogs |
| 02/04/2015 | EP2832359A1 Diquafosol-containing eye drop |
| 02/04/2015 | EP2832353A1 Drug composition, and soft capsule containing same |
| 02/04/2015 | EP2832352A1 Capsule disintegrable in large-intestine-specific manner |
| 02/04/2015 | EP2832350A1 Method for producing disintegrating particulate composition comprising acid-type carboxymethylcellulose, disintegrating particulate composition comprising acid-type carboxymethylcellulose, and orally disintegrating tablet including disintegrating particulate composition comprising acid-type carboxymethylcellulose |
| 02/04/2015 | EP2832349A1 Lactate-based fulvestrant or fulvestrant derivative oily preparation and preparation method thereof |
| 02/04/2015 | EP2832348A1 Method for dissolving flavonoid compound, carbon glycoside compound, or stilbene compound and method for preparing injection or powder for injection |
| 02/04/2015 | EP2832346A1 Aqueous dispersed composition |